Is neratinib following trastuzumab in early-stage HER2-positive breast cancer cost-effective?

被引：0
|
作者：
Schwartz, Naomi R. M.
Flanagan, Meghan Rose
Babigumira, Joseph B.
Steuten, Lotte Maria Gertruda
Roth, Joshua A.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.6625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6625
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Patterns in use and tolerance of adjuvant neratinib in patients with hormone receptor (HR)-positive, HER2-positive early-stage breast cancer
    Blanter, Julia
    Baldwin, Elena
    Patel, Rima
    Sheng, Tianxiang
    Tiersten, Amy
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
  • [22] Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer
    Iwata, Hiroji
    Masuda, Norikazu
    Kim, Sung-Bae
    Inoue, Kenichi
    Rai, Yoshiaki
    Fujita, Takashi
    Chiu, Joanne
    Ohtani, Shoichiro
    Takahashi, Masato
    Miyaki, Toshiko
    Lu, Yen-Shen
    Xu, Binghe
    Yap, Yoon Sim
    Bustam, Anita
    Yao, Bin
    Zhang, Bo
    Bryce, Richard
    Chan, Arlene
    [J]. FUTURE ONCOLOGY, 2019, 15 (21) : 2489 - 2501
  • [23] Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer
    O'Brien D.R.
    Boe L.
    Montagna G.
    Mueller B.
    Chino F.
    Cuaron J.
    Choi J.I.
    Xu A.
    Bernstein M.
    McCormick B.
    Powell S.
    Khan A.J.
    Braunstein L.Z.
    [J]. International Journal of Radiation Oncology Biology Physics, 2024, 118 (02): : 468 - 473
  • [24] Neratinib in HER2-Positive Breast Cancer Patients
    Paranjpe, Rutugandha
    Basatneh, Dima
    Tao, Gabriel
    De Angelis, Carmine
    Noormohammed, Sobia
    Ekinci, Ekim
    Abughosh, Susan
    Ghose, Romi
    Trivedi, Meghana V.
    [J]. ANNALS OF PHARMACOTHERAPY, 2019, 53 (06) : 612 - 620
  • [25] Neratinib (Nerlynx) for HER2-Positive Breast Cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1539): : 23 - 23
  • [26] US Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
    Singh, Harpreet
    Walker, Amanda J.
    Amiri-Kordestani, Laleh
    Cheng, Joyce
    Tang, Shenghui
    Balcazar, Pamela
    Barnett-Ringgold, Kimberly
    Palmby, Todd R.
    Coo, Xianhua
    Zheng, Nan
    Liu, Qi
    Yu, Jingyu
    Pierce, William F.
    Daniels, Selena R.
    Sridhara, Rajeshwari
    Ibrahim, Amna
    Kluetz, Paul G.
    Blumenthal, Gideon M.
    Beaver, Julia A.
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (15) : 3486 - 3491
  • [27] Neratinib in extended adjuvant therapy for HER2-positive early breast cancer
    Kubiatowski, Tomasz
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (04): : 201 - 205
  • [28] Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
    Veeraraghavan, Jamunarani
    Gutierrez, Carolina
    Sethunath, Vidyalakshmi
    Mehravaran, Sepideh
    Giuliano, Mario
    Shea, Martin J.
    Mitchell, Tamika
    Wang, Tao
    Nanda, Sarmistha
    Pereira, Resel
    Davis, Robert
    Goutsouliak, Kristina
    Qin, Lanfang
    De Angelis, Carmine
    Diala, Irmina
    Lalani, Alshad S.
    Nagi, Chandandeep
    Hilsenbeck, Susan G.
    Rimawi, Mothaffar F.
    Osborne, C. Kent
    Schiff, Rachel
    [J]. NPJ BREAST CANCER, 2021, 7 (01)
  • [29] Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
    Cadoo, Karen A.
    Morris, Patrick G.
    Cowell, Elizabeth P.
    Patil, Sujata
    Hudis, Clifford A.
    McArthur, Heather L.
    [J]. CLINICAL BREAST CANCER, 2016, 16 (06) : 487 - 493
  • [30] COST-EFFECTIVENESS ANA LYSIS OF 1-YEAR ADJUVANT TRASTUZUMAB THERAPY OF EARLY-STAGE HER2-POSITIVE BREAST CANCER
    Nguyen, T. T. C.
    Nguyen, T. T. T.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A735 - A735
12345